0001209191-11-039504.txt : 20110714 0001209191-11-039504.hdr.sgml : 20110714 20110714150238 ACCESSION NUMBER: 0001209191-11-039504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110713 FILED AS OF DATE: 20110714 DATE AS OF CHANGE: 20110714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Emmens Matthew CENTRAL INDEX KEY: 0001298332 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 11967872 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST., ATTN: GENERAL COUNSEL CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-07-13 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001298332 Emmens Matthew C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 1 1 0 0 CEO & President Stock Option 51.75 2011-07-13 4 A 0 118000 0.00 A 2011-10-13 2021-07-12 Common Stock 118000 118000 D Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011. Valerie L. Andrews, Attorney-In-Fact 2011-07-14